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Morphine Attenuates Endothelial Cell Adhesion Molecules 
Induced by the Supernatant of LPS-Stimulated Colon Cancer Cells
A large reservoir of bacterial lipopolysaccharide (LPS) is available in the colon and this 
could promote colon cancer metastasis by enhancing tumor cell adhesion, intravasation, 
and extravasation. Furthermore, adhesion molecules like ICAM-1, VCAM-1, and 
E-selectin play important roles in the adhesion of tumor cells to endothelium. This study 
was designed to determine whether morphine can attenuate the expressions of adhesion 
molecules up-regulated by the supernatant of LPS-stimulated HCT 116 colon cancer cells 
(LPS-Sup). In this study, we divided to three groups by cell-growth medium of human 
umbilical vascular endothelial cells (HUVECs): the control group was incubated in growth 
factor-free endothelial medium, the Sup group was incubated in the supernatant of HCT 
116 cells (Sup), and the LPS-Sup group was incubated in LPS-Sup. To observe effect of 
morphine to the adhesion molecules expressions in the LPS-Sup group, we co-treated 
morphine with LPS or added it to LPS-Sup. Adhesion molecule expressions on HUVECs in 
all three groups were measured during incubation period. Consquentially, ICAM-1, 
VCAM-1, and E-selectin expressions on HUVECs were significantly lower when morphine 
was co-treated with LPS than not co-treated. Thus, we suggest that morphine affects 
the expressions of adhesion molecules primarily by attenuating LPS stimuli on tumor 
cells.
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ORIGINAL ARTICLE
Oncology & Hematology
INTRODUCTION
The metastasis of tumor cells is a multistep process. The impor-
tant steps in the metastatic cascade of tumor cell are intravasa-
tion, dissemination, and extravasation (1). During intravasation 
tumor cells traverse the basement membrane and the endothe-
lium of blood vessel walls into the blood stream. During extrav-
asation tumor cells penetrate the vascular endothelium and the 
underlying basement membrane from their luminal sides. Im-
portantly, both of these steps require adhesion between tumor 
cells and endothelium. This adhesion is made possible by the 
expression of adhesion molecules such as intercellular adhesion 
molecule-1 (ICAM-1), vascular cell adhesion molecule (VCAM-
1), and E-selectin on endothelium. The first step in the cell ad-
hesion cascade, so-called rolling, is regulated by selectins like 
E-selectin. Adhesion and migration predominantly involve in-
tegrins and members of the immunoglobulin supergene family 
such as ICAM-1 and VCAM-1. Tumor cells are often surround-
ed by inflammatory cells which secrete various cytokines such 
as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) 
and bacterial lipopolysaccharide (LPS). These cytokines are 
known to be involved in tumor promotion, and cell adhesion 
(2). A large reservoir of LPS is available in the colon, because 
bacteria like Escherichia coli typically produce copious amounts 
of LPS, and thus inflammation around colon cancer cells can 
cause much LPS release. This LPS stimulates to secrete various 
cytokines and pro-inflammatory mediators (3, 4). The effects of 
cytokines and pro-inflammatory mediators on adhesion mole-
cules expressions are not clear, but in a previous study, it was 
demonstrated that the supernatant of LPS-stimulated HT-29 
colon cancer cells up-regulates adhesion molecules on endo-
thelial cells.
  Morphine has been used for analgesia in cancer for many 
years. Furthermore, Sasamura et al. (5) found that morphine 
can inhibit the growth and metastasis of tumor cells in a mouse 
model, and Harimaya et al. (6) showed that morphine can also 
inhibit the adhesion, invasion and metastasis of metastatic co-
lon carcinoma cells. In addition, other studies (7-9) have dem-
onstrated that morphine attenuates the expressions of adhesion 
molecules on endothelial cells. However, no previous study has 
examined the inhibitory effect of morphine on the vascular in-
vasion of tumor cells. In the present study, we investigated wheth-
er morphine can attenuate the expressions of endothelial adhe-
sion molecules induced on HUVECs by the supernatant of LPS-Min TJ, et al.  •  Morphine-Effect to Adhesion Molecules Upregulated by LPS-Stimulated Supernatant 
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stimulated HCT 116 colon cancer cells.
 
MATERIALS AND METHODS
Cell lines and reagents
The human umbilical vascular endothelial cell (HUVEC) line 
(JG-C2517A, single donor) and its medium (EGM
®-2; endothe-
lial growth medium with BulletKit
® [CC-3162]) were purchased 
from Lonza (Walkersville, MD, USA). The HCT 116 colon carci-
noma cell (CCL-247) line was from ATCC (Manassas, VA, USA) 
and was cultured in RPMI-1640 (R1145). PE Mouse Anti-Human 
CD54, CD62E, CD 106 antidodies are from Becton Dickinson 
(BD) (cat. 555749; Franklin Lakes, NJ, USA), and all the other re-
agents were from Sigma Chemicals (St. Louis, MO, USA).
Cell cultures
HUVECs were cultured in EGM containing 10% fetal bovine calf 
serum, endothelial growth supplement (CC-4113); hEGF 0.5 mL, 
Hydrocortisone 0.5 mL, a 5% penicillin/streptomycin (CC-4381), 
and 25 μg/mL heparin (CC-4936), and maintained at 37°C in 5% 
CO2 humidified atmosphere. All experiments utilized cells grown 
between two and three passages. The HCT 116 cell line was cul-
tured in RPMI-1640 medium supplemented with L-glutamine 
(300 mg/L), 25 mM HEPES and 25 mM NaHCO3, 10% heat-in-
activated fetal bovine serum, and 100 U/mL penicillin/100 μg/
mL streptomycin, and maintained at 37°C in 5% CO2 humidi-
fied atmosphere. All cells were subcultured following enzymat-
ic digestion using trypsin/EDTA solution.
Cell viabilities
Cell viabilities were measured by cell counting. First, cells were 
removed from cultures and placed in test tubes. The samples were 
diluted four times and stained with trypan blue, cover-slipped 
in a hemocytometer, and observed under an optical microscope. 
Finally, cells with an intact membrane were counted.
Experimental protocols
HUVECs were grown in EGM until they coated 70%-80% of dish 
surfaces. The EGM was then replaced with growth factor-free 
EGM. In the control group, ICAM-1, VCAM-1 and E-selectin were 
measured at 0, 4, 8, 12, and 24 hr of incubation period in growth 
factor-free EGM (Fig. 1). 
  HCT 116 cancer cells were grown in RPMI 1640 medium un-
til they coated 80%-90% of dish surfaces. The RPMI 1640 medi-
um was then replaced with growth factor-free EGM, and cells 
were incubated for 24 hr and supernatant was then harvested. 
In the Sup group, HUVECs were incubated for 24 hr in the super-
natant of HCT 116 cancer cells. On the other hand, in the LPS-
Sup group, HCT 116 cancer cells were stimulated with 1 μg/mL 
of LPS for 4 hr. Cells were then throughly washed and growth 
hormone-free EGM was added to ensure that observed effects 
on HUVECs were due to substances produced by the tumor cells 
and not by residual stimulants. HUVECs were then incubated 
for 24 hr in LPS-Sup. ICAM-1, VCAM-1 and E-selectin were mea-
sured at 0, 4, 8, 12, and 24 hr of incubation period (Fig. 1).
  In addition, HUVECs were also treated as follows: 1) 0.01, 0.1, 
or 1 μM of morphine was co-treated with LPS during LPS-stim-
ulation on the HCT 116 cells (Morphine + LPS), or 2) 0.01, 0.1, 
or 1 μM of morphine was added to LPS-Sup during incubation 
period (Morphine + LPS-Sup) (Fig. 2).
Flow cytometry
The surface expressions of adhesion molecules were measured 
by flow cytometry (Facsflow from BD) by using an ICAM-1 spe-
cific fluorescein isothiocyanate–labeled antibody from BD 
(Franklin Lakes, NJ, USA). Briefly, cells were washed with phos-
phate buffered saline (PBS) and then trypsinized. After detach-
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Fig. 1. Experimental protocol. The control group; HUVECs were incubated in growth 
factor-free endothelial medium. The Sup group; HUVECs were incubated in the super-
natant of HCT 116 cells. The LPS-Sup; HUVECs were incubated in the supernatant of 
LPS-stimulated HCT 116 cells.
Fig. 2. Experimental protocol. Morphine was co-treated in two ways: 1) Morphine + 
LPS; co-treating morphine with LPS during stimulation of HCT 116 cells or 2) Mor-
phine + LPS-Sup; adding morphine to LPS-Sup prior to incubation of HUVECs. EGM 
is an endothelial cell growth medium without endothelial growth hormone. 
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ing cells and transferring them into tubes, the digestion was 
stopped by the adding medium 199 that contained 10% fetal 
calf serum. After centrifugation at 218 g, (4°C, 5 min), tubes were 
washed with PBS. The cells were incubated with PE Mouse Anti-
Human CD54, CD62E, and CD 106 for 30 min at 4°C, rewashed 
with PBS and resuspended in 500 μL PBS for flow cytometric 
analysis. To adjust instrument settings, control cells were pre-
pared by using the procedure described above, but omitting 
antibody. At least three different sets of experiments with cells 
from different isolations were performed in triplicate.
Statistical analysis
We used SPSS for Windows version 10.0 (SPSS, Chicago, IL, USA) 
for the statistical analysis. All results, which are expressed as 
means ± SDs, are representative of three different experiments. 
Flow cytometry results were evaluated by one-way ANOVA. 
Significance was accepted for P values of < 0.05.
 
RESULTS
Cell viabilities
The cell survival rates of HUVECs in growth factor-free EGM, in 
the supernatant of HCT 116 cancer cells, and in the supernatant 
of LPS-stimulated HCT 116 cancer cells were 96%. No signifi-
cant time-dependent differences were observed between these 
treatments.
The expressions of ICAM-1, VCAM-1, and E-selectin on 
HUVECs after incubation in growth hormone-free EGM, 
Sup, or LPS-Sup
In the Sup group, the expressions of VCAM-1 and E-selectin were 
not significantly increased as compared to the control group, 
but the expression of ICAM-1 was significantly higher after in-
cubation for 8 and 12 hr. In the LPS-Sup group, the expressions 
of ICAM-1, VCAM-1 and E-selectin were significantly greater 
than in the control group througout 24-hr incubation period 
(Fig. 3).
The expression of ICAM-1 on HUVECs after 0.01, 0.1, or  
1 μM of morphine was added to LPS-Sup or co-treated with 
LPS
ICAM-1 expression on HUVECs was significantly attenuated at 
8, 12, and 24 hr of incubation period by co-treating 0.1 μM of 
morphine with LPS and at 8 hr of incubation period by co-treat-
ing 1 μM of morphine with LPS. Otherwise, we could not observe 
down-regulated of ICAM-1 expression on HUVECs by adding 
morphine to LPS-Sup or co-treating 0.01 μM of morphine with 
LPS (Fig. 4A).
The expression of VCAM-1 on HUVECs after 0.01, 0.1, or  
1 μM of morphine was added to LPS-Sup or co-treated 
with LPS
VCAM-1 expression on HUVECs was significantly attenuated at 
8 and 12 hr of incubation period by co-treating 0.1 or 1 μM of 
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Fig. 3. Up-regulations of the expressions of the adhesion molecules on the HUVEC 
cells by LPS-Sup. Graphs show the expressions of ICAM-1, VCAM-1, and E-selectin 
on HUVECs during a 24-hr of incubation period. ICAM-1, VCAM-1, and E-selectin ex-
pressions in the LPS-Sup and Sup groups were compared versus those in the control 
group. Percentages of positive cells were recorded at 0, 4, 8, 12, and 24 hr of incu-
bation period. Values are expressed as means ± SD. *P < 0.05 vs the control group; 
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expressed as means ± SD. (D) Histograms show the characterization of ICAM-1, VCAM-1, and E-selectin expressions on HUVECs at 8-hr of incubation period. Control means 
unstained value. LPS + 0.1 µM of morphine means the value of when 0.1 µM morphine was co-treated with LPS in the LPS-Sup group. The percentage of positive cells from 
each group was recorded at 0, 4, 8, 12, and 24 hr of incubation period. In gray box, values are expressed as percentages of gated positive cells. *P < 0.05 versus the LPS-Sup 
group; 
†P < 0.05 versus Morphine + LPS-Sup.
Fig. 4. The effect of morphine on 
the expressions of adhesion mole-
cules on HUVECs. (A) Graphs show 
the expressions of ICAM-1 on HU-
VECs incubated in LPS-Sup, Mor-
phine + LPS-Sup and supernatant 
of Morphine + LPS. (B) Graphs 
show the expressions of VCAM-1 
on HUVECs incubated in LPS-Sup, 
Morphine + LPS-Sup and superna-
tant of Morphine + LPS. (C) Graphs 
show the expressions of E-selectin 
on HUVECs incubated in LPS-Sup, 
Morphine + LPS-Sup and superna-
tant of Morphine + LPS. Values are 
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morphine with LPS, but this was also observed at 24 hr of incu-
bation period by co-treating 0.1 μM of morphine. Otherwise, 
we could not observe down-regulated VCAM-1 expression on 
HUVECs by adding morphine to LPS-Sup or co-treating 0.01 μM 
of morphine with LPS (Fig. 4B).
The expression of E-selectin on HUVECs after 0.01, 0.1, or 
1 μM of morphine was added to LPS-Sup or co-treated 
with LPS
E-selectin expression on HUVECs was significantly attenuated 
at 8, 12, 24 hr of incubation period by co-treating 0.1 or 1 μM of 
morphine with LPS. Otherwise, we could not observe down-reg-
ulated E-selectin expression on HUVECs by adding morphine to 
LPS-Sup or co-treating 0.01 μM of morphine with LPS (Fig. 4C).
DISCUSSION
In cancer patients, morphine is mainly used to relieve pain in 
order to improve the quality of life. However, the analgesic dos-
ages administered vary substantially (10), and thus, we choose 
a morphine dosage, based on a previous clinical study (11). In 
the previous study, the effective dosage of morphine required 
for analgesia was achieved at the blood concentrations between 
0.1 and 0.4 μM. Therefore, we used 0.01, 0.1, or 1 μM of morphine 
in this study.
  When tumor cells are surrounded by inflammatory cells, they 
secrete various soluble factors such as IL-1β, TNF-α, and LPS. 
Simiantonaki et al. (12) reported that LPS-stimulated tumor cells 
supernatant increased adhesion molecules expressions, such 
as, of ICAM-1, VCAM-1, and E-selectin on HUVECs as compared 
with the nonstimulated, or IL-1β, or TNF-α stimulated tumor 
cells supernatant. In particular, LPS-stimulated supernatant of 
colon cancer cells such as HT-29 and HRT-18 more highly stim-
ulated the expressions of ICAM-1, VCAM-1, and E-selectin when 
LPS was used as a stimulant. In the present study we observed 
that LPS-Sup induced higher expressions of ICAM-1, VCAM-1, 
and E-selectin than medium of the control group (Fig. 3). Vidal-
Vanaclocha et al. (13) demonstrated that systemic inflamma-
tion induced by LPS enhances the metastatic potential of B16 
melanoma cells in vivo and in vitro, and Andrews et al. (14) found 
that the metastatic colon carcinoma cell line LS174T showed 
increased adhesion to HUVECs after exposure to LPS and also 
found that these adhesions involve a NF-κB-dependent path-
way. Furthermore, it is known that the transcription factor NF-
κB (nuclear factor kappa-light-chain-enhancer of activated B 
cells) controls the gene expressions of E-selectin, ICAM-1, and 
VCAM-1 (15). 
  In colon cancer cells, LPS causes the synthesis and secretion 
of a variety of cytokines and other pro-inflammatory mediators 
(16, 17), though the effect of LPS stimulation to up-regulation of 
adhesion molecules on tumor cells is still unclear. Furthermore, 
IL-8, IL-6, and vascular endothelial growth factor are promoted 
by LPS in ovarian cancer cells (3) and IL-8 synthesis is increased 
by LPS stimulation in non-small cell lung cancer cells (4). More-
over, it is known that IL-1β and IL-6 are highly induced by tu-
mors that metastasize to the liver, such as breast cancer and co-
lon carcinoma (18). Thornton et al. (19) reported that the endo-
thelial expressions of ICAM-1 and VCAM-1 are induced by IL-1β 
via an NF-κB-dependent pathway and Weber et al. (9) described 
that TNF-α significantly induces messenger RNA (mRNA) and 
protein expression of adhesion molecules like ICAM-1, VCAM-1 
and E-selectin on HUVECs. 
  The anti-tumor and anti-metastatic effects of morphine are 
considered to be mainly due to indirect mechanisms involving 
pain relief (20) and to the elimination of pain-associated stress 
(21). However, Hariyama et al. (6) found that the metastasis of 
colon 26-L5 cells was reduced by morphine, although no evi-
dence of hyperalgesia at cancer-inoculated sites was observed 
in their mouse model. These findings suggest that morphine 
directly down-regulates the invasive and metastatic potential of 
tumor cells. Wang et al. (8) demonstrated that serum levels of 
ICAM-1 and L-selectin were significantly elevated in patients 
with a myocardial infarction and that these elevated serum lev-
els of ICAM-1 and L-selectin were attenuated by morphine. In 
an vitro study, Weber et al. (9) recently found that morphine can 
attenuate the expression of ICAM-1 on HUVECs by reducing NF-
κB activity and we also demonstrated that morphine can down-
regulate the expression of ICAM-1 and neutrophil adhesion on 
HUVECs during ischemic-reperfusion period (22). Moreover, 
Ohno et al. (23) reported that DHMEQ (NF-κB inhibitor) inhib-
its adhesion between HUVECs and HT-29 colon cancer cells by 
reducing the expressions of ICAM-1, VCAM-1 and E-selectin on 
HUVECs. In our study, morphine was not found to down-regu-
late the expression of ICAM-1, VCAM-1, and E-selectin on HU-
VECs directly, and yet the expressions of ICAM-1, VCAM-1, and 
E-selectin were significantly reduced on HUVECs when mor-
phine was co-treated during LPS-stimulation (Fig. 4). It seems 
that morphine affects the expressions of adhesion molecules 
primarily by attenuating LPS stimuli on tumor cells rather than 
by directly down-regulating the expressions of adhesion mole-
cules on HUVECs.
  Although the effect of morphine on tumor metastasis is un-
clear, based on our observations, we believe that morphine can 
reduce LPS-stimulated metastasis in colon cancer by attenuat-
ing the expressions of adhesion molecules on endothelial cells. 
In the future, we plan to evaluate the mechanism responsible 
for the effect of morphine on LPS-stimulated metastasis in vitro 
and to investigate the anti-metastatic effect of morphine in vivo.
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A large source of bacterial LPS is available in colon and the LPS might promote colon cancer metastasis by enhancing tumor cell 
adhesion to endothelium. We tested whether morphine treatment could attenuate the expressions of adhesion molecules in 
endothelial cells (HUVEC) that was stimulated by the supernatant of LPS-stimulated HCT 116 colon cancer cells.  The expressions of 
adhesion molecules on HUVECs were significantly lower when morphine was co-treated with LPS than without morphine co-
treatment. Thus, we suggest that morphine could reduce the LPS-stimulated metastasis in colon cancer by attenuating the 
expressions of adhesion molecules on endothelial cells.